Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 31 (17) 2173-2181
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Comprehensive
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
758   851   854   856   857   858  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
R01 CA165958  
Corr. Author:
 
Authors:
                                           
Networks:
 
Study
CALGB-9633
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Thor3, Thor5, Thor12, To2, To20, ORIGINAL REPORTS, Thoracic Oncology